No connection

Search Results

HIT vs NVDA

HIT
Health In Tech, Inc.
BEARISH
Price
$1.34
Market Cap
$87.8M
Sector
Technology
AI Confidence
85%
NVDA
NVIDIA Corporation
BULLISH
Price
$182.08
Market Cap
$4.43T
Sector
Technology
AI Confidence
85%

Valuation

P/E Ratio
HIT
67.0
NVDA
37.16
Forward P/E
HIT
7.24
NVDA
16.38
P/B Ratio
HIT
4.51
NVDA
28.13
P/S Ratio
HIT
2.64
NVDA
20.49
EV/EBITDA
HIT
29.98
NVDA
32.83

Profitability

Gross Margin
HIT
62.82%
NVDA
71.07%
Operating Margin
HIT
-2.27%
NVDA
65.02%
Profit Margin
HIT
3.84%
NVDA
55.6%
ROE
HIT
8.45%
NVDA
101.48%
ROA
HIT
4.92%
NVDA
51.19%

Growth

Revenue Growth
HIT
53.1%
NVDA
73.2%
Earnings Growth
HIT
--
NVDA
95.6%

Financial Health

Debt/Equity
HIT
0.01
NVDA
0.07
Current Ratio
HIT
3.13
NVDA
3.9
Quick Ratio
HIT
2.31
NVDA
3.14

Dividends

Dividend Yield
HIT
--
NVDA
0.02%
Payout Ratio
HIT
0.0%
NVDA
0.82%

AI Verdict

HIT BEARISH

HIT presents a high-risk profile characterized by a Piotroski F-Score of 4/9 (Stable) but severe technical deterioration. While the company exhibits strong revenue growth (53.10%) and an exceptionally clean balance sheet (Debt/Equity 0.01), it is trading at a massive premium to its Graham Number ($0.37) and Intrinsic Value ($0.14). The stock is currently in a freefall with a 0/100 technical trend and a 60.8% decline over the last six months, coupled with a poor earnings track record of 0/4 beats.

Strengths
Strong YoY and Q/Q revenue growth of ~53%
Negligible debt levels (Debt/Equity 0.01)
Robust liquidity with a Current Ratio of 3.13
Risks
Severe bearish technical trend (0/100 score)
Significant overvaluation relative to Graham and Intrinsic values
Negative operating margin (-2.28%) indicating operational inefficiency
NVDA BULLISH

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.

Strengths
Hyper-growth trajectory with 95.6% YoY earnings growth
Elite profitability with a 65.02% operating margin
Exceptional balance sheet strength (Debt/Equity of 0.07 and Current Ratio of 3.90)
Risks
Significant insider selling totaling $208.13M in the last 6 months
Bearish short-term technical trend (0/100 score)
High Price-to-Book ratio (28.13) indicating a steep premium over assets

Compare Another Pair

HIT vs NVDA: Head-to-Head Comparison

This page compares Health In Tech, Inc. (HIT) and NVIDIA Corporation (NVDA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile